Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
Terns Pharmaceuticals (TERN) Ownership - Who Owns Terns Pharmaceuticals?
80 Followers
Terns Pharmaceuticals (TERN) Ownership Overview
The ownership structure of Terns Pharmaceuticals (TERN) stock is a mix of institutional, retail and individual investors. Approximately 90.94% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 9.06% is owned by Public Companies and Individual Investors.
0.00% Insiders
17.81% Mutual Funds
73.13% Other Institutional Investors
9.06% Public Companies and
Individual Investors
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 28, 2022 | Orbimed Advisors Llc Director, >10% Owner | Bought | $1000000 |
| Dec 28, 2022 | Carl Gordon Director, >10% Owner | Bought | $1000000 |
| Dec 23, 2022 | Lu Hongbo Director | Bought | $5499995 |
| Dec 23, 2022 | Vivo Opportunity, Llc >10% Owner | Bought | $5499995 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Bought | $417379 | |
| Sep 30, 2023 | Bought | $5407250 | |
| Sep 30, 2023 | Sold | $8138137 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,148,037.00 | Institution | 6.71% | 28,248,131.97 | |
| 2,040,000.00 | Institution | 3.30% | 13,892,400.00 | |
| 2,023,443.00 | Institution | 3.27% | 13,779,646.83 | |
| 1,903,768.00 | Institution | 3.08% | 12,964,660.08 | |
| 1,898,743.00 | Institution | 3.07% | 12,930,439.83 | |
| 1,761,192.00 | Institution | 2.85% | 11,993,717.52 | |
| 1,617,920.00 | Institution | 2.62% | 11,018,035.20 | |
| 1,075,000.00 | Institution | 1.74% | 7,320,750.00 | |
| 1,001,806.00 | Institution | 1.62% | 6,822,298.86 | |
| 658,996.00 | Institution | 1.07% | 4,487,762.76 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,148,037.00 | Institution | 6.71% | 28,248,131.97 | |
| 1,761,192.00 | Institution | 2.85% | 11,993,717.52 | |
| 1,001,806.00 | Institution | 1.62% | 6,822,298.86 | |
| 658,996.00 | Institution | 1.07% | 4,487,762.76 | |
| 559,200.00 | Institution | 0.90% | 3,808,152.00 | |
| 454,600.00 | Institution | 0.74% | 3,095,826.00 | |
| 407,912.00 | Institution | 0.66% | 2,777,880.72 | |
| 366,835.00 | Institution | 0.59% | 2,498,146.35 | |
| 332,668.00 | Institution | 0.54% | 2,265,469.08 | |
| 228,489.00 | Institution | 0.37% | 1,556,010.09 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,066,634.00 | Institution | 1.73% | 7,263,777.54 | |
| 1,218,066.00 | Institution | 1.97% | 6,407,027.00 | |
| 532,520.00 | Institution | 0.86% | 2,801,055.00 | |
| 253,555.00 | Institution | 0.41% | 1,726,709.55 | |
| 244,144.00 | Institution | 0.40% | 1,662,620.64 | |
| 130,375.00 | Institution | 0.21% | 887,853.75 | |
| 128,362.00 | Institution | 0.21% | 675,184.00 | |
| 95,796.00 | Institution | 0.16% | 652,370.76 | |
| 106,689.00 | Institution | 0.17% | 561,184.00 | |
| 43,138.00 | Institution | 0.07% | 293,769.78 |
FAQ
Who Owns Terns Pharmaceuticals (TERN)?
According to the latest TipRanks data, approximately 73.13% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 9.06% is held by retail investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 73.13% of Terns Pharmaceuticals (TERN) stock is held by institutional investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.06% of Terns Pharmaceuticals (TERN) stock is held by retail investors.
Who owns the most shares of Terns Pharmaceuticals (TERN)?
Fidelity Securities Fund owns the most shares of Terns Pharmaceuticals (TERN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.